Low Endotoxin Release from Escherichia coli and Bacteroides fragilis during Exposure to Moxifloxacin

Publisher： Karger

E-ISSN： 1421-9794|56|5|364-370

ISSN： 0009-3157

Source： Chemotherapy, Vol.56, Iss.5, 2010-10, pp. : 364-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro Bactericidal Activitiesand Morphologic Changes in Escherichia coli and Bacteroides fragilis by Cephalosporins

By  

Chemotherapy, Vol. 44, Iss. 3, 1998-05 ,pp. : 157-163

Karger

Access to resources Recommend Favorite

Therapeutic Efficacy of Moxifloxacin, a New Quinolone, in the Treatment of Experimental Intra-Abdominal Abscesses Induced by Bacteroides fragilis in Mice

By  

Chemotherapy, Vol. 50, Iss. 2, 2004-06 ,pp. : 76-80

Karger

Access to resources Recommend Favorite

Antimicrobial Resistance in Commensal Escherichia coli from Pigs during Metaphylactic Trimethoprim and Sulfamethoxazole Treatment and in the Post-Exposure Period

By Mazurek Justyna   Bok Ewa   Stosik Michał   Baldy-Chudzik Katarzyna  

International Journal of Environmental Research and Public Health, Vol. 12, Iss. 2, 2015-02 ,pp. : 2150-2163

MDPI

Access to resources Recommend Favorite

Vitamin B12 Uptake by the Gut Commensal Bacteria Bacteroides thetaiotaomicron Limits the Production of Shiga Toxin by Enterohemorrhagic Escherichia coli

By Cordonnier Charlotte   Le Bihan Guillaume   Emond-Rheault Jean-Guillaume   Garrivier Annie   Harel Josée   Jubelin Grégory  

Toxins, Vol. 8, Iss. 1, 2016-01 ,pp. : 14-14

MDPI

Access to resources Recommend Favorite

Comparison of the Bactericidal Activity of Moxifloxacin and Levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae

By  

Chemotherapy, Vol. 49, Iss. 1-2, 2003-05 ,pp. : 33-35

Karger

Access to resources Recommend Favorite